Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-22 Purchase | 2024-11-15 8:34 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 2,400 | $25.91 | $62,176 | 36,080 (Indirect Direct) | View |
| 2024-07-02 Sale | 2024-07-03 5:27 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 9,394 | $25.28 | $237,480 | 127,107 (Direct) | View |
| 2024-05-02 Sale | 2024-05-06 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,799 | $23.31 | $41,935 | 30,205 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 6:05 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 6,000 | $28.03 | $168,180 | 204,851 (Direct) | View |
| 2024-03-18 Purchase | 2024-03-20 7:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 3,000 | $27.66 | $82,990 | 33,680 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 5:54 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 40,000 | $35.19 | $1,407,600 | 400,600 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 5:25 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $32.35 | $1,860,019 | 4,066,774 (Direct) | View |
| 2024-01-12 Sale | 2024-01-17 6:32 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 7,940 | $36.89 | $292,904 | 210,851 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 2,911 | $38.06 | $110,788 | 129,711 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 3,934 | $38.07 | $149,759 | 47,870 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 3,147 | $38.06 | $119,787 | 60,778 (Direct) | View |
| 2024-01-11 Sale | 2024-01-16 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 4,720 | $38.1 | $179,813 | 32,001 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 5:17 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 74 | $33.89 | $2,508 | 136,501 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 5:16 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 16,104 | $35.27 | $567,910 | 440,600 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 5:16 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer | 8,303 | $35.26 | $292,804 | 198,497 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 8:02 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 38,443 | $34.69 | $1,333,529 | 218,791 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 7:58 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 33,190 | $34.36 | $1,140,362 | 464,385 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 5:25 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 9,952 | $31.01 | $308,637 | 3,715,048 (Direct) | View |
| 2023-12-20 Sale | 2023-12-22 5:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 12,000 | $28.54 | $342,480 | 3,725,000 (Direct) | View |
| 2023-11-20 Sale | 2023-11-22 2:31 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer | 19,700 | $28.8 | $567,315 | 131,800 (Direct) | View |
| 2023-10-25 Sale | 2023-10-27 6:23 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 24,338 | $24.21 | $589,223 | 3,737,000 (Direct) | View |
| 2023-09-28 Sale | 2023-10-02 5:51 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,550 | $26.33 | $40,812 | 21,734 (Direct) | View |
| 2023-09-18 Sale | 2023-09-20 6:10 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,755 | $28.12 | $1,624,223 | 4,170,563 (Direct) | View |
| 2023-07-03 Sale | 2023-07-06 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 8,925 | $35.31 | $315,142 | 61,575 (Direct) | View |
| 2023-06-30 Sale | 2023-07-05 6:15 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 3,000 | $35.53 | $106,590 | 188,484 (Direct) | View |
| 2023-06-27 Sale | 2023-06-29 6:41 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 15,000 | $36.2 | $543,000 | 381,704 (Direct) | View |
| 2023-05-05 Sale | 2023-05-08 6:29 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 6,500 | $40.9 | $265,850 | 143,135 (Indirect Direct) | View |
| 2023-05-03 Sale | 2023-05-05 7:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $39.32 | $4,125,674 | 4,745,298 (Direct) | View |
| 2023-03-03 Sale | 2023-03-06 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 11,350 | $32.65 | $370,578 | 7,867 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 6:14 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 875 | $32.62 | $28,542 | 149,635 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-25 Ownership | 2024-11-15 8:34 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 5,650 | $0 | 36,080 (Direct) | View |
Ownership | 2024-11-15 8:34 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 0 | $0 | 36,080 (Indirect) | View |
Ownership | 2024-03-18 7:00 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Lu Hongbo Director | 0 | $0 | 30,680 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 5:25 pm | 2015-02-06 2024-02-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $0 | 4,066,774 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 5:25 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $14.54 | 4,066,774 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 5:17 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 75,000 | $0 | 136,501 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 5:16 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 75,000 | $0 | 440,600 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 5:16 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer | 75,000 | $0 | 198,497 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 8:02 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Chief Discovery/Trans Medicine | 75,000 | $0 | 218,791 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 7:58 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 85,000 | $0 | 464,385 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 4:03 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 14,987 | $25.41 | 65,825 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:55 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director | 14,987 | $25.41 | 114,754 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:54 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director | 14,987 | $25.41 | 22,854 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:52 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 14,987 | $25.41 | 36,721 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:51 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director | 14,987 | $25.41 | 132,622 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 3:41 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director | 14,987 | $25.41 | 51,804 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-20 6:10 pm | 2013-10-01 2023-09-21 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,555 | $0 | 4,170,563 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-20 6:10 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,755 | $4.75 | 4,170,563 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 7:04 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $2.01 | 4,745,298 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 7:04 pm | 2013-06-01 2023-05-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $0 | 4,745,298 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-12 3:23 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director | 12,460 | $0 | 55,431 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:38 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director | 12,460 | $0 | 35,860 (Direct) | View |
| 2023-01-10 Disposition | 2023-01-11 8:35 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 1,764 | $0 | 27,877 (Direct) | View |
| 2023-01-10 Option Award | 2023-01-11 8:35 pm | 2024-01-10 2033-01-10 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director | 12,460 | $0 | 27,877 (Direct) | View |